Pressreleases

Register Now for Natoli’s 2014 Training Course: Theory & Practice of Modern Tablet Manufacturing, QC/QA

This hands-on course was developed using the latest techniques, theories and processes to train individuals involved with the design, formulation, unit operations, manufacture, quality control/quality assurance, and bioavailability/bioequivalence of pharmaceutical tablets. The course will take place on 21-23 October, 2014.

Limited Seating Available for Natoli’s 2014 Hands-On Technical Training Course

Natoli Engineering Company, Inc. will host their most popular technical training course, Basics of tablet manufacturing and troubleshooting, at their state-of-the-art Technical Training Centre in St. Charles, MO. The two-day course was developed using the latest techniques, theories and processes to train tooling technicians, tablet press operators, tablet press maintenance technicians, quality control/quality assurance personnel, research and development, and supervisors. 16-18 September, 2014.

Malvern Technology Delivers Its Reliability in Multi-Disciplinary Lab at Queen Mary University London

The cross-disciplinary capabilities of Malvern Instruments’ technology are being fully exploited at Queen Mary University London. The Zetasizer Nano, NanoSight Nanoparticle Tracking Analysis (NTA) and Mastersizer 2000 systems are all employed within the university’s multi-disciplinary lab. The instruments serve a wide variety of research groups working in areas as diverse as silica coating formulation through to tissue regeneration, demonstrating the value that Malvern’s robust technology brings throughout the scientific arena.

PRA Health Sciences Files for Initial Public Offering

PRA Health Sciences, Inc. announced today that it has filed a registration statement on Form S-1 with the US Securities and Exchange Commission (SEC) relating to a proposed initial public offering ('IPO') of shares of its common stock by PRA Health Sciences and an affiliate of Kohlberg Kravis Roberts & Co. L.P. (the 'selling stockholder'). The number of shares to be offered and the price range has not yet been determined.

PRA Health Sciences Expands in Pennsylvania

Blue Bell, Pennsylvania will soon be home to PRA Health Sciences' largest office worldwide. PRA, a leading global contract research organisation (CRO), is relocating employees from its Horsham and Fort Washington locations into new modern class A+ office space in Blue Bell. The new office marks the first phase of the relocation plan.

Q&A: Rodeina Challand, Executive Director Biosimilar Development on the Naming of Biosimilars – the INN Debate

With the publication of the WHO draft proposal for the naming of biologics, what is the potential impact on the business of biosimilars?

Registration Opens for Respiratory Drug Delivery Asia 2014

The Respiratory Drug Delivery (RDD®) Asia 2014 scientific conference will welcome pulmonary and nasal drug delivery experts from all over the world to Goa, India, from 12-14 November 2014.

Fujifilm Diosynth Biotechnologies Expands Cell Culture Manufacturing Capacity

Fujifilm Diosynth Biotechnologies has announced continued expansion of its cell culture manufacturing capabilities with the addition of two 2,000L single-use bioreactors. One each of these is being installed at the company's sites in Research Triangle Park (RTP), NC, USA and Billingham, UK.

CurTec to Introduce New Packaging at CPhI 2014

For nearly 20 years pharmaceutical companies have chosen CurTec containers for bulk packaging of tablets. In the mid-90s MSD started using CurTec drums. Since then the number of customers has increased and we provide one million drums annually for this application. But why do customers find CurTec packaging so special?